Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Bolt Biotherapeutics (BOLT)

Annual Return

Over the past 3 years, BOLT has had an average annual return of -45.45%, underperforming the benchmark SPY, which returned +19.31% annual.

Over the past 5 years, BOLT has had an average annual return of -55.50%, underperforming the benchmark SPY, which returned +12.55% annual.

Since Feb 5, 2021, BOLT has had an average annual return of -59.73%, underperforming the benchmark SPY, which returned +14.19% annual.

202620252024202320222021
-17.65%-48.80%-52.30%-13.86%-73.49%-84.76%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026+8.24%-23.91%-10.00%+19.05%+9.33%-26.83%+16.67%-17.65%
2025-8.43%-2.63%-16.22%-10.48%-11.71%-8.16%-2.22%-9.09%+3.75%+8.43%-12.22%+7.59%-48.80%
2024-9.77%+13.06%+22.54%-20.92%-31.69%-0.85%-0%-9.44%-4.27%-2.48%+1.02%-16.58%-52.30%
2023+13.12%+9.63%-13.77%+13.66%+8.96%-25.61%+5.53%-18.57%-5.56%-5.57%-13.11%+31.32%-13.86%
2022-21.65%-9.05%-21.55%-43.08%+9.07%+20.04%+6.30%-17.04%-17.86%-6.09%+6.48%-12.17%-73.49%
2021-16.95%+23.25%-32.05%-21.70%-11.70%-27.89%+59.28%-28.77%+3.48%-29.20%-47.14%-84.76%

Drawdown analysis of Bolt Biotherapeutics (BOLT)

The maximum drawdown for the BOLT was -99.52%, occurring on Jul 10, 2026. This drawdown has not yet recovered.

The current BOLT drawdown is -99.44%.

Since Feb 5, 2021 BOLT has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 2 times
  • 10% or more: 2 times
DepthStartTo BottomBottomTo RecoverEndTotal
-99.52%Mar 17, 20211334Jul 10, 2026OngoingOngoingOngoing
-22.69%Feb 10, 202111Feb 26, 20217Mar 9, 202118
-0.51%Mar 12, 20211Mar 15, 20211Mar 16, 20212
-0.20%Mar 9, 20211Mar 10, 20211Mar 11, 20212